@article{GS14947,
author = {Nisar Zaidi and Despoina Daskalaki and Pablo Quadri and Alexis Okoh and Pier Cristoforo Giulianotti and Eren Berber},
title = {The current status of robotic transaxillary thyroidectomy in the United States: an experience from two centers},
journal = {Gland Surgery},
volume = {6},
number = {4},
year = {2017},
keywords = {},
abstract = {Background: Few studies exist regarding the state of robotic transaxillary thyroidectomy (RT) and its outcomes at high-volume institutions.
Methods: Eighty-nine patients underwent RT between January 2009 and September 2015 at two tertiary centers. Data were collected from prospectively-maintained IRB-approved databases. Patient demographic and clinical data, and trends were evaluated.
Results: Indications for RT included biopsy-proven or suspicion for malignancy in 20.2%, atypical cells or follicular neoplasm in 27.7%, multinodular goiter in 26.6%, thyrotoxicosis in 8.5%, need for completion thyroidectomy in 5.3%, and non-diagnostic FNA in 3.2%. 56% underwent total thyroidectomy and 44% lobectomy. Operative time (OT) was 153.5 minutes for lobectomies and 192.6 minutes for total thyroidectomy. The complication rate was 11.7%: temporary RLN neuropraxia in 2 patients, permanent hypoparathyroidism in 1 patient, temporary hypoparathyroidism in 6 patients, flap seroma in 1 patient, and flap hematoma in 1 patient. Pathology showed malignancy in 43 patients. At a mean follow-up of
31.9 months, there were no recurrences. Since 2013, the number of RTs performed has risen. The number of out-of-state patients increased from 18% to 37% after 2011.
Conclusions: RT was performed without compromising outcomes in selected patients. There remains interest among patients seeking this procedure in expert centers.},
issn = {2227-8575}, url = {https://gs.amegroups.org/article/view/14947}
}